Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Barriers to cardiovascular prevention].

S Scardi1, C Mazzone

  • 1Centro Cardiovascolare Azienda Sanitaria Triestina Via Farneto, 3 34100 Trieste. sabino.scardi@ass1.sanita.fvg.it

Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology
|November 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rituximab for the treatment of patients with chronic lymphocytic leukemia.

Cancer management and research·2010
Same author

Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.

Transplant infectious disease : an official journal of the Transplantation Society·2010
Same author

Autoimmune hemolityc anemia concomitant with sequential autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Hashimoto's thyroiditis: a new entity of autoimmune polyendocrine syndrome.

Journal of endocrinological investigation·2009
Same author

Insights into defibrotide: an updated review.

Expert opinion on biological therapy·2009
Same author

The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia.

Leukemia·2006
Same author

Physical methods for preventing deep vein thrombosis in stroke.

The Cochrane database of systematic reviews·2004

Effective coronary artery disease prevention requires overcoming patient, physician, and system barriers through improved guidelines, professional training, and coordinated healthcare efforts. Addressing these challenges is key to successful risk factor management.

Area of Science:

  • Cardiovascular Medicine
  • Public Health Policy
  • Health Services Research

Context:

  • Evidence from observational and clinical trials supports coronary artery disease (CAD) prevention recommendations.
  • Numerous implementation barriers hinder risk reduction interventions.
  • These barriers span patient, physician, healthcare organization, financial, social, and policy domains.

Purpose:

  • To identify obstacles to implementing CAD risk reduction interventions.
  • To outline strategies for overcoming these barriers.
  • To emphasize the need for a coordinated healthcare system approach.

Summary:

  • Identified barriers include patient adherence, physician/organizational factors, financial/social issues, and policy limitations.
  • Proposed strategies involve developing clear clinical guidelines, enhancing professional training, implementing effective management programs (including non-physician roles), and integrating risk management into quality indicators.

Related Experiment Videos

  • Cost-effectiveness and patient compliance are crucial considerations.

    • Impact:

    • Successful CAD risk factor management necessitates an efficient healthcare system.
    • Coordinated efforts among primary care physicians, cardiovascular specialists, nurses, and government policymakers are essential.
    • Improved implementation strategies can lead to better population cardiovascular health outcomes.